Report cover image

Global Crude Heparin Market Research Report 2022

Publisher QYResearch Group
Published Jan 28, 2022
Length 106 Pages
SKU # QYR16951855

Description

Global Crude Heparin Market Research Report 2022

Summary

Due to the COVID-19 pandemic, the global Crude Heparin market size is estimated to be worth US$ 3.75 billion in 2021 and is forecast to a readjusted size of US$ 8.32 billion by 2028 with a CAGR of 10.90% during the review period. Fully considering the economic change by this health crisis, the Europe Crude Heparin market is estimated at US$ 0.79 billion in 2022, while the United States and China are forecast to reach US$ 1.6 billion and US$ 4.34 billion by 2028, respectively. The proportion of the United States is 19.02% in 2022, while Chinese percentage is 51.92%, and it is predicted that China market share will reach 52.18% in 2028.
Pig Intestine Mucosa Heparin accounting for 99.35% of the Crude Heparin global market in 2021, is projected to value US$ 8.23 billion by 2028, growing at a revised 10.83% CAGR in the post-COVID-19 period. While UFH segment is altered to an 4.79% CAGR throughout this forecast period and will hold a share about 10% in 2028.
The global major manufacturers of Crude Heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, and Hepac (Darling Ingredients), etc. In terms of revenue, the global 3 largest players have a 37.46% market share of Crude Heparin in 2021.
This report focuses on Crude Heparin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Crude Heparin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.
Global Crude Heparin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

Segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others

Segment by Application
UFH
LMWH

By Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
South Korea
India
Southeast Asia

Europe
Germany
UK
France
Spain
Italy

South America
Mexico
Brazil
Argentina

Middle East & Africa
Saudi Arabia
UAE
Egypt
Turkey
South Africa

Table of Contents

106 Pages
1 Crude Heparin Market Overview
1.1 Product Overview and Scope of Crude Heparin
1.2 Crude Heparin Segment by Type
1.2.1 Global Crude Heparin Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Crude Heparin Segment by Application
1.3.1 Global Crude Heparin Sales Comparison by Application (2017-2028)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Crude Heparin Market Size Estimates and Forecasts
1.4.1 Global Crude Heparin Revenue 2017-2028
1.4.2 Global Crude Heparin Sales 2017-2028
1.4.3 Crude Heparin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Crude Heparin Market Competition by Manufacturers
2.1 Global Crude Heparin Sales Market Share by Manufacturers (2017-2022)
2.2 Global Crude Heparin Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Crude Heparin Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Crude Heparin Manufacturing Sites, Area Served, Product Type
2.5 Crude Heparin Market Competitive Situation and Trends
2.5.1 Crude Heparin Market Concentration Rate
2.5.2 The Global 5 and 3 Largest Crude Heparin Players Market Share by Revenue
2.5.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Crude Heparin Retrospective Market Scenario by Region
3.1 Global Crude Heparin Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Crude Heparin Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Crude Heparin Market Facts & Figures by Country
3.3.1 North America Crude Heparin Sales by Country
3.3.2 North America Crude Heparin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Crude Heparin Market Facts & Figures by Country
3.4.1 Europe Crude Heparin Sales by Country
3.4.2 Europe Crude Heparin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Spain
3.5 Asia Pacific Crude Heparin Market Facts & Figures by Region
3.5.1 Asia Pacific Crude Heparin Sales by Region
3.5.2 Asia Pacific Crude Heparin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Southeast Asia
3.6 Latin America Crude Heparin Market Facts & Figures by Country
3.6.1 Latin America Crude Heparin Sales by Country
3.6.2 Latin America Crude Heparin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Crude Heparin Market Facts & Figures by Country
3.7.1 Middle East and Africa Crude Heparin Sales by Country
3.7.2 Middle East and Africa Crude Heparin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Crude Heparin Historic Market Analysis by Type
4.1 Global Crude Heparin Sales Market Share by Type (2017-2022)
4.2 Global Crude Heparin Revenue Market Share by Type (2017-2022)
4.3 Global Crude Heparin Price by Type (2017-2022)
5 Crude Heparin Historic Market Analysis by Application
6 Key Companies Profiled
6.1 Bioiberica
6.1.1 Bioiberica Corporation Information
6.1.2 Bioiberica Description and Business Overview
6.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bioiberica Crude Heparin Product Portfolio
6.2 Shenzhen Hepalink
6.2.1 Shenzhen Hepalink Corporation Information
6.2.2 Shenzhen Hepalink Description and Business Overview
6.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Shenzhen Hepalink Crude Heparin Product Portfolio
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Crude Heparin Product Portfolio
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Corporation Information
6.4.2 Nanjing King-friend Description and Business Overview
6.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nanjing King-friend Crude Heparin Product Portfolio
6.5 Fengrun Biological Technology
6.5.1 Fengrun Biological Technology Corporation Information
6.5.2 Fengrun Biological Technology Description and Business Overview
6.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Fengrun Biological Technology Crude Heparin Product Portfolio
6.6 Aspen Oss
6.6.1 Aspen Oss Corporation Information
6.6.2 Aspen Oss Description and Business Overview
6.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Aspen Oss Crude Heparin Product Portfolio
6.7 Hebei Changshan Biochemical
6.7.1 Hebei Changshan Biochemical Corporation Information
6.7.2 Hebei Changshan Biochemical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.7.4 Hebei Changshan Biochemical Crude Heparin Product Portfolio
6.8 Changzhou Qianhong
6.8.1 Changzhou Qianhong Corporation Information
6.8.2 Changzhou Qianhong Description and Business Overview
6.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Changzhou Qianhong Crude Heparin Product Portfolio
6.9 Hepac (Darling Ingredients)
6.9.1 Hepac (Darling Ingredients) Corporation Information
6.9.2 Hepac (Darling Ingredients) Description and Business Overview
6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Portfolio
6.10 Huaian MDC Pharmaceutical
6.10.1 Huaian MDC Pharmaceutical Corporation Information
6.10.2 Huaian MDC Pharmaceutical Description and Business Overview
6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Description and Business Overview
6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
7 Crude Heparin Manufacturing Cost Analysis
7.1 Crude Heparin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Crude Heparin
7.4 Crude Heparin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Crude Heparin Distributors List
8.3 Crude Heparin Customers
9 Crude Heparin Market Dynamics
9.1 Crude Heparin Industry Growth Opportunities
9.2 Crude Heparin Market Drivers
9.3 Crude Heparin Market Challenges and Restraints
10 Global Market Forecast
10.1 Crude Heparin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Crude Heparin by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Crude Heparin by Type (2023-2028)
10.2 Crude Heparin Market Estimates and Projections by Application
10.3 Crude Heparin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Crude Heparin by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Crude Heparin by Region (2023-2028)
11 Research Findings and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Crude Heparin Sales Growth Rate Comparison by Type (2022-2028) & (Tonnes) & (US$ Million)
Table 2. Table Detailed Description of Heparin API
Table 3. Global Crude Heparin Sales Growth Rate Comparison by Application (2017-2028) & (Tonnes)
Table 4. Global Crude Heparin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Crude Heparin Market Competitive Situation by Manufacturers in 2021
Table 6. Global Crude Heparin Sales (Tonnes) of Key Manufacturers (2017-2022)
Table 7. Global Crude Heparin Sales Market Share by Manufacturers (2017-2022)
Table 8. Global Crude Heparin Revenue (US$ Million) by Manufacturers (2017-2022)
Table 9. Global Crude Heparin Revenue Share by Manufacturers (2017-2022)
Table 10. Global Market Crude Heparin Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Crude Heparin Manufacturing Sites and Area Served
Table 12. Manufacturers Crude Heparin Product Type
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2021)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Crude Heparin Sales by Region (2017-2022) & (Tonnes)
Table 17. Global Crude Heparin Sales Market Share by Region (2017-2022)
Table 18. Global Crude Heparin Revenue by Region (2017-2022) & (US$ Million)
Table 19. Global Crude Heparin Revenue Market Share by Region (2017-2022)
Table 20. North America Crude Heparin Sales by Country (2017-2022) & (Tonnes)
Table 21. North America Crude Heparin Sales Market Share by Country (2017-2022)
Table 22. North America Crude Heparin Revenue by Country (2017-2022) & (US$ Million)
Table 23. North America Crude Heparin Revenue Market Share by Country (2017-2022)
Table 24. Europe Crude Heparin Sales by Country (2017-2022) & (Tonnes)
Table 25. Europe Crude Heparin Sales Market Share by Country (2017-2022)
Table 26. Europe Crude Heparin Revenue by Country (2017-2022) & (US$ Million)
Table 27. Europe Crude Heparin Revenue Market Share by Country (2017-2022)
Table 28. Asia Pacific Crude Heparin Sales by Region (2017-2022) & (Tonnes)
Table 29. Asia Pacific Crude Heparin Sales Market Share by Region (2017-2022)
Table 30. Asia Pacific Crude Heparin Revenue by Region (2017-2022) & (US$ Million)
Table 31. Asia Pacific Crude Heparin Revenue Market Share by Region (2017-2022)
Table 32. Latin America Crude Heparin Sales by Country (2017-2022) & (Tonnes)
Table 33. Latin America Crude Heparin Sales Market Share by Country (2017-2022)
Table 34. Latin America Crude Heparin Revenue by Country (2017-2022) & (US$ Million)
Table 35. Latin America Crude Heparin Revenue Market Share by Country (2017-2022)
Table 36. Middle East and Africa Crude Heparin Sales by Country (2017-2022) & (Tonnes)
Table 37. Middle East and Africa Crude Heparin Sales Market Share by Country (2017-2022)
Table 38. Middle East and Africa Crude Heparin Revenue by Country (2017-2022) & (US$ Million)
Table 39. Middle East and Africa Crude Heparin Revenue Market Share by Country (2017-2022)
Table 40. Global Crude Heparin Sales by Type (2017-2022) & (Tonnes)
Table 41. Global Crude Heparin Sales Market Share by Type (2017-2022)
Table 42. Global Crude Heparin Revenue by Type (2017-2022) & (US$ Million)
Table 43. Global Crude Heparin Revenue Share by Type (2017-2022)
Table 44. Global Crude Heparin Price by Type (2017-2022) & (US$/Kg)
Table 45. Global Crude Heparin Sales (Tonnes) by Application (2017-2022)
Table 46. Global Crude Heparin Sales Market Share by Application (2017-2022)
Table 47. Bioiberica Corporation Information
Table 48. Bioiberica Description and Business Overview
Table 49. Bioiberica Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 50. Bioiberica Crude Heparin Product
Table 51. Shenzhen Hepalink Corporation Information
Table 52. Shenzhen Hepalink Description and Business Overview
Table 53. Shenzhen Hepalink Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 54. Shenzhen Hepalink Crude Heparin Product
Table 55. Sanofi Corporation Information
Table 56. Sanofi Description and Business Overview
Table 57. Sanofi Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 58. Sanofi Crude Heparin Product
Table 59. Nanjing King-friend Corporation Information
Table 60. Nanjing King-friend Description and Business Overview
Table 61. Nanjing King-friend Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. Nanjing King-friend Crude Heparin Product
Table 63. Fengrun Biological Technology Corporation Information
Table 64. Fengrun Biological Technology Description and Business Overview
Table 65. Fengrun Biological Technology Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 66. Fengrun Biological Technology Crude Heparin Product
Table 67. Aspen Oss Corporation Information
Table 68. Aspen Oss Description and Business Overview
Table 69. Aspen Oss Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 70. Aspen Oss Crude Heparin Product
Table 71. Hebei Changshan Biochemical Corporation Information
Table 72. Hebei Changshan Biochemical Description and Business Overview
Table 73. Hebei Changshan Biochemical Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 74. Hebei Changshan Biochemical Crude Heparin Product
Table 75. Changzhou Qianhong Corporation Information
Table 76. Changzhou Qianhong Description and Business Overview
Table 77. Changzhou Qianhong Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 78. Changzhou Qianhong Crude Heparin Product
Table 79. Hepac (Darling Ingredients) Corporation Information
Table 80. Hepac (Darling Ingredients) Description and Business Overview
Table 81. Hepac (Darling Ingredients) Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Hepac (Darling Ingredients) Crude Heparin Product
Table 83. Huaian MDC Pharmaceutical Corporation Information
Table 84. Huaian MDC Pharmaceutical Description and Business Overview
Table 85. Huaian MDC Pharmaceutical Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 86. Huaian MDC Pharmaceutical Crude Heparin Product
Table 87. Yantai Dongcheng Biochemicals Corporation Information
Table 88. Yantai Dongcheng Biochemicals Description and Business Overview
Table 89. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tonnes), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 90. Yantai Dongcheng Biochemicals Crude Heparin Product
Table 91. Key Suppliers of Raw Materials
Table 92. Crude Heparin Distributors List
Table 93. Crude Heparin Customers List
Table 94. Crude Heparin Market Growth Opportunities
Table 95. Crude Heparin Market Drivers
Table 96. Crude Heparin Market Challenges and Restraints
Table 97. Global Crude Heparin Sales Forecast by Type (2023-2028) & (Tonnes)
Table 98. Global Crude Heparin Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Crude Heparin Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Crude Heparin Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Crude Heparin Sales Forecast by Application (2023-2028) & (Tonnes)
Table 102. Global Crude Heparin Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Crude Heparin Sales Forecast by Region (2023-2028) & (Tonnes)
Table 104. Global Crude Heparin Sales Market Share Forecast by Region (2023-2028)
Table 105. Global Crude Heparin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 106. Global Crude Heparin Revenue Market Share Forecast by Region (2023-2028)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Crude Heparin
Figure 2. Global Crude Heparin Revenue Market Share by Type: 2022
Figure 3. Pig Intestine Mucosa Heparin Product Picture
Figure 4. Bovine Heparin and Others Product Picture
Figure 5. Global Crude Heparin Sales Market Share by Application: 2022
Figure 6. UFH
Figure 7. LMWH
Figure 8. Global Crude Heparin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Crude Heparin Market Size (2017-2028) & (US$ Million)
Figure 10. Global Crude Heparin Sales (2017-2028) & (Tonnes)
Figure 11. Crude Heparin Sales Share by Manufacturers in 2021 11

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us